Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia.
New England Journal of Medicine, 2021 BACKGROUND Immune thrombocytopenia is a rare autoimmune disorder with associated bleeding risk and fatigue. Recommended first-line treatment for immune thrombocytopenia is high-dose glucocorticoids, but side effects, variable responses, and high relapse ...
C. Bradbury +12 more
semanticscholar +1 more source
Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case. [PDF]
, 2017 Thrombopoietin receptor agonists (TPO-RAs) are used as effective alternative treatments in ITP patients unresponsive to first-/second-line therapies.
Baldacci, Erminia +7 more
core +1 more source
Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review
SN Comprehensive Clinical Medicine, 2020 Immune thrombocytopenia, often known as immune thrombocytopenic purpura (ITP), has emerged as an important complication of COVID-19. A systematic review was done to analyze the clinical profile and outcomes in a total of 45 cases of new-onset ITP in ...
Sukrita Bhattacharjee, M. Banerjee
semanticscholar +1 more source
A Retrospective Observational Single-Centre Study on the Burden of Immune Thrombocytopenia (ITP) [PDF]
, 2012 Background: German data on economic consequences of immune thrombocytopenia (ITP) are limited. Patients and Methods: A retrospective, observational study based on chart review of adult patients with a confirmed diagnosis of ITP was conducted at a German ...
Ackermann, Birgit +6 more
core +1 more source
American Society of Hematology 2019 guidelines for immune thrombocytopenia.
Blood Advances, 2019 BACKGROUND Despite an increase in the number of therapies available to treat patients with immune thrombocytopenia (ITP), there are minimal data from randomized trials to assist physicians with the management of patients. OBJECTIVE These evidence-based
C. Neunert +16 more
semanticscholar +1 more source
SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia
New England Journal of Medicine, 2021 The coronavirus disease 2019 (Covid-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) stimulated the development of highly effective vaccines that were produced wi...
D. Cines, J. Bussel
semanticscholar +1 more source
The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents [PDF]
, 2005 Strong thrombocytopenia is observed during acute infection with Trypanosoma cruzi, the parasitic protozoan agent of American trypanosomiasis or Chagas' disease.
Campetella, O. +4 more
core +2 more sources
Blood Advances, 2019 Over the last decade, there have been numerous developments and changes in treatment practices for the management of patients with immune thrombocytopenia (ITP). This article is an update of the International Consensus Report published in 2010.
D. Provan +21 more
semanticscholar +1 more source
Vaccine-induced immune thrombotic thrombocytopenia
Blood, 2023 Visual ...
D. Cines, A. Greinacher
semanticscholar +1 more source
Eltrombopag for the treatment of immune thrombocytopenia: The aegean region of Turkey experience [PDF]
, 2015 Objective: Immune thrombocytopenia (ITP) is an immune-mediated disease characterized by transient or persistent decrease of the platelet count to less than 100x109/L. Although it is included in a benign disease group, bleeding complications may be mortal.
Alacacıoğlu, İ. +21 more
core +3 more sources